Similar articles

• Adjuvant therapy for pancreatic and periampullary cancer.

  Tandon V. Tandon V. Trop Gastroenterol. 2000 Jul-Sep;21(3):129-30. Trop Gastroenterol. 2000. PMID: 11084835 No abstract available.
• Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.

  Abrams RA, Yeo CJ. Abrams RA, et al. Surg Oncol Clin N Am. 2004 Oct;13(4):621-38, ix. doi: 10.1016/j.soc.2004.06.004. Surg Oncol Clin N Am. 2004. PMID: 15350938 Review.
• Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.

  Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH. Morak MJ, et al. Ann Surg. 2008 Dec;248(6):1031-41. doi: 10.1097/SLA.0b013e318190c53e. Ann Surg. 2008. PMID: 19092348 Clinical Trial.
• Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.

  O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD. O'Connor JK, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6. doi: 10.1016/j.ijrobp.2005.03.036. Epub 2005 Jun 22. Int J Radiat Oncol Biol Phys. 2005. PMID: 15978737
• Multimodality management of localized pancreatic cancer.

  Wayne JD, Wolff RA, Pisters PW, Evans DB. Wayne JD, et al. Cancer J. 2001 Jul-Aug;7 Suppl 1:S35-46. Cancer J. 2001. PMID: 11504284 Review.